Immediate Impact

13 from Science/Nature 72 standout
Sub-graph 1 of 23

Citing Papers

Atogepant for the preventive treatment of chronic migraine (PROGRESS): a randomised, double-blind, placebo-controlled, phase 3 trial
2023 Standout
Psychedelics reopen the social reward learning critical period
2023 StandoutNature
3 intermediate papers

Works of Christopher Gottschalk being referenced

Exploratory Controlled Study of the Migraine-Suppressing Effects of Psilocybin
2020
Indoleamine Hallucinogens in Cluster Headache: Results of the Clusterbusters Medication Use Survey
2015
and 2 more

Author Peers

Author Last Decade Papers Cites
Christopher Gottschalk 257 109 464 303 271 30 1.1k
Christian Kissling 231 105 312 231 256 18 1.2k
DJ Nutt 128 24 342 187 399 32 1.1k
Paul Ragan 150 111 684 188 200 19 1.3k
Madeleine V. King 74 40 635 166 207 29 1.1k
Sophie Holmes 174 15 389 339 210 42 1.3k
I‐Shin Shiah 451 24 385 178 180 47 1.3k
Ravi Das 120 26 504 496 246 53 1.3k
Branimir Jernej 232 35 491 190 149 41 1.1k
Bernard Albaugh 83 179 404 128 174 25 1.1k
L. Demisch 282 40 195 170 132 55 903

All Works

Loading papers...

Rankless by CCL
2026